Shigeru Kawabata

Also affiliated with University of Shimane, Shimane University Hospital, Osaka University of Pharmaceutical Sciences

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia”.

Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia

International Journal of Oncology(2023)10.3892/ijo.2023.5576

N/A

0.312DataRank · unranked

7 citations

Joell J. Gills, Shigeru Kawabata, Masahiro Onozawa, Giusy Della Gatta, Adolfo A. Ferrando +3 more

Combining Nelfinavir With Chloroquine InhibitsIn VivoGrowth of Human Lung Cancer Xenograft Tumors

In Vivo(2021)10.21873/invivo.12241

N/A

0DataRank · unranked

9 citations

Shigeru Kawabata, Joell J. Gills, Phillip A. Dennis, Jaclyn LoPiccolo